Yeganeh Reuven 4
4 · BiomX Inc. · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
BiomX (PHGE) 10% Owner Yeganeh Reuven Sells Shares
What Happened Yeganeh Reuven, reported as a 10% owner (via Pyu Pyu Capital, LLC), converted Series Y convertible preferred stock into common stock and then sold the resulting securities across March 16–17, 2026. The filing shows conversions of 450,000 shares (3/16) and 530,000 shares (3/17) at a $2.00 conversion price (total cost $1,960,000), and multiple disposals/sales totaling approximately 5,980,000 shares that generated roughly $29,972,000 in proceeds. Several small conversion/disposition line items at $0.00 were also reported (900 and 1,060 shares). Overall the transactions show acquisitions via conversion followed by substantial sales (net material sell activity).
Key Details
- Transaction dates: March 16–17, 2026; Form 4 filed March 18, 2026.
- Conversions (acquisitions): 450,000 @ $2.00 on 3/16 ($900,000); 530,000 @ $2.00 on 3/17 ($1,060,000). Total converted = 980,000 shares ($1,960,000).
- Sales (dispositions): 450,000 @ $5.00; 530,000 @ $5.00; 1,300,000 @ $5.00; 2,000,000 @ $5.24; 1,700,000 @ $4.76 — total ≈ 5,980,000 shares for ≈ $29,972,000.
- Footnotes: F1 — conversions were from Series Y Convertible Preferred at $2.00/share. F2 — reported securities are directly owned by Pyu Pyu Capital, LLC; Reuven is sole member and disclaims beneficial ownership except pecuniary interest. F3 — some common-stock sales were private transactions at $5.00/share. F4 — warrants were sold in private transactions at the stated prices.
- Shares owned after the transactions are not specified in the filing.
- Filing timeliness: Form 4 filed 3/18/2026 reporting 3/16–3/17 transactions; no late filing flag noted.
Context
- These were conversions of preferred shares into common (a form of purchase/acquisition) followed by sales; conversions reduced preferred holdings and increased common shares available for sale. Because converted shares were immediately or shortly thereafter sold, this resembles a conversion + sale (not a long-term buy-and-hold purchase).
- As a reported 10% owner acting through an LLC, this is institutional/major-holder activity rather than routine executive compensation trades; the filing’s footnote clarifies the ownership structure.
- Sales included private transactions (per footnotes) and sales of derivative-related securities (warrants) at specified private prices. These items are factual disclosures and do not necessarily indicate the insider’s investment view.
Insider Transaction Report
- Conversion
Common Stock, $0.0001 par value per share
[F1][F2]2026-03-16$2.00/sh+450,000$900,000→ 450,000 total(indirect: By LLC) - Sale
Common Stock, $0.0001 par value per share
[F3][F2]2026-03-16$5.00/sh−450,000$2,250,000→ 0 total(indirect: By LLC) - Conversion
Common Stock, $0.0001 par value per share
[F1][F2]2026-03-17$2.00/sh+530,000$1,060,000→ 530,000 total(indirect: By LLC) - Sale
Common Stock, $0.0001 par value per share
[F3][F2]2026-03-17$5.00/sh−530,000$2,650,000→ 0 total(indirect: By LLC) - Conversion
Series Y Convertible Preferred Stock
[F1][F2]2026-03-16−900→ 1,060 total(indirect: By LLC)Exercise: $2.00From: 2026-01-13Exp: 2027-01-13→ Common Stock (450,000 underlying) - Conversion
Series Y Convertible Preferred Stock
[F1][F2]2026-03-17−1,060→ 0 total(indirect: By LLC)Exercise: $2.00From: 2026-01-13Exp: 2027-01-13→ Common Stock (530,000 underlying) - Sale
Common Stock Purchase Warrants
[F4][F2]2026-03-16$5.00/sh−1,300,000$6,500,000→ 2,000,000 total(indirect: By LLC)Exercise: $1.00From: 2026-01-13Exp: 2031-01-13→ Common Stock (1,300,000 underlying) - Sale
Common Stock Purchase Warrants
[F4][F2]2026-03-16$5.24/sh−2,000,000$10,480,000→ 1,700,000 total(indirect: By LLC)Exercise: $1.00From: 2026-01-13Exp: 2031-01-13→ Common Stock (300,000 underlying) - Sale
Common Stock Purchase Warrants
[F4][F2]2026-03-16$4.76/sh−1,700,000$8,092,000→ 0 total(indirect: By LLC)Exercise: $1.00From: 2026-01-13Exp: 2031-01-13→ Common Stock (1,700,000 underlying)
Footnotes (4)
- [F1]Represents shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer received upon conversion of the Issuer's Series Y Convertible Preferred Stock, par value $0.0001 per share, held by the Reporting Person at a conversion price equal to $2.00 per share.
- [F2]The reported securities are directly owned by Pyu Pyu Capital, LLC ("Pyu Pyu") and may be deemed to be beneficially owned by the Reporting Person as sole member of Pyu Pyu. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F3]The shares of Common Stock were sold in private transactions at a price of $5.00 per share.
- [F4]The warrants were sold in private transactions at the specified price per warrant share.